Operative costs associated with arthroscopic assisted open reduction and internal fixation of acute ankle fractures.


Journal

Foot (Edinburgh, Scotland)
ISSN: 1532-2963
Titre abrégé: Foot (Edinb)
Pays: Scotland
ID NLM: 9109564

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 05 11 2020
revised: 23 11 2020
accepted: 29 11 2020
pubmed: 17 1 2021
medline: 26 10 2021
entrez: 16 1 2021
Statut: ppublish

Résumé

Ankle fractures are a common orthopedic injury that frequently involves associated cartilage lesions, soft tissue damage, and a significant inflammatory burden. Despite studies revealing intra-articular pathology in up to 79% of ankle fractures, only 1% of open reduction and internal fixation (ORIF) procedures undergo arthroscopic evaluation. The primary purpose of this study was to determine the cost effectiveness of ankle arthroscopy performed at time of ORIF for ankle fracture. An IRB approved retrospective review of patients who sustained ankle fractures and underwent ORIF with and without concomitant arthroscopic surgery between 2015 and 2020 were investigated. Patient demographics, fracture characteristics, outcomes, and cost data were collected and analyzed. There were 567 total ORIF and 28 ORIF and scope included for cost analysis purposes. Total surgical costs averaged $6,537.62 and $6,886.46 for the ORIF only and ORIF and scope procedures respectively. Total direct costs, including operating room time, for the same procedures were found to average $6,212.34 and $7,312.10 for the ORIF only and ORIF and scope procedures respectively. The cost difference between the ORIF only and with arthroscopy was not statistically significant (p = 0.1174). Twelve of the 28 arthroscopic patients (42.86%) had grade 3 or full thickness chondral lesions, and 11/28 (39.28%) arthroscopic patients were found to have grade 1-2 cartilage changes. In the acute treatment of ankle fractures, concurrent arthroscopic evaluation does not add a significant cost to the procedure and may result in improved short and long term benefits for the patient. With improved arthroscopic efficiency, the cost differential can be further reduced. LOE: IV.

Sections du résumé

BACKGROUND BACKGROUND
Ankle fractures are a common orthopedic injury that frequently involves associated cartilage lesions, soft tissue damage, and a significant inflammatory burden. Despite studies revealing intra-articular pathology in up to 79% of ankle fractures, only 1% of open reduction and internal fixation (ORIF) procedures undergo arthroscopic evaluation. The primary purpose of this study was to determine the cost effectiveness of ankle arthroscopy performed at time of ORIF for ankle fracture.
METHODS METHODS
An IRB approved retrospective review of patients who sustained ankle fractures and underwent ORIF with and without concomitant arthroscopic surgery between 2015 and 2020 were investigated. Patient demographics, fracture characteristics, outcomes, and cost data were collected and analyzed.
RESULTS RESULTS
There were 567 total ORIF and 28 ORIF and scope included for cost analysis purposes. Total surgical costs averaged $6,537.62 and $6,886.46 for the ORIF only and ORIF and scope procedures respectively. Total direct costs, including operating room time, for the same procedures were found to average $6,212.34 and $7,312.10 for the ORIF only and ORIF and scope procedures respectively. The cost difference between the ORIF only and with arthroscopy was not statistically significant (p = 0.1174). Twelve of the 28 arthroscopic patients (42.86%) had grade 3 or full thickness chondral lesions, and 11/28 (39.28%) arthroscopic patients were found to have grade 1-2 cartilage changes.
CONCLUSION CONCLUSIONS
In the acute treatment of ankle fractures, concurrent arthroscopic evaluation does not add a significant cost to the procedure and may result in improved short and long term benefits for the patient. With improved arthroscopic efficiency, the cost differential can be further reduced. LOE: IV.

Identifiants

pubmed: 33453610
pii: S0958-2592(20)30103-6
doi: 10.1016/j.foot.2020.101765
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101765

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

R Danilkowicz (R)

Duke University Medical Center, Dept. Orthopaedic Surgery, Durham, NC, United States.

B Lau (B)

Duke University Medical Center, Dept. Orthopaedic Surgery, Durham, NC, United States.

J Kim (J)

Duke University Medical Center, Dept. Orthopaedic Surgery, Durham, NC, United States.

K Dai (K)

Duke University Medical Center, Dept. Orthopaedic Surgery, Durham, NC, United States.

C Akoh (C)

Duke University Medical Center, Dept. Orthopaedic Surgery, Durham, NC, United States.

S Adams (S)

Duke University Medical Center, Dept. Orthopaedic Surgery, Durham, NC, United States.

A Amendola (A)

Duke University Medical Center, Dept. Orthopaedic Surgery, Durham, NC, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH